±èÀçÇö ¸íÀÇ

´ç´¢ ȯÀÚ¿¡°Ô Èñ¸ÁÀ» ÁÖ´Â ´ç´¢ ±ÇÀ§ÀÚ

±èÀçÇö ¸íÀÇ

  • ¼Ò ¼Ó
    »ï¼º¼­¿ïº´¿ø
  • Áø·á°ú
    ³»ºÐºñ³»°ú
  • Àü¹®ºÐ¾ß
    ´ç´¢º´, 1Çü´ç´¢º´, ºÎ½ÅÁúȯ

±èÀçÇö ±³¼ö´Â ³­Ä¡¼º ´ç´¢º´ Àü¹®°¡·Î ¸í¼ºÀÌ ³ôÀ¸¸ç, ƯÈ÷ 1Çü ´ç´¢º´¿¡ ´ëÇÑ ÀÎ½Ä °³¼±°ú Á¦µµ ¹ßÀü¿¡ ´Ù¹æ¸éÀ¸·Î Ȱµ¿ÇØ ¿Ô´Ù. ±èÀçÇö ±³¼ö´Â ´ëÇÑ´ç´¢º´ÇÐȸ ÃéµµºÎÀü ´ç´¢º´ TFÆÀÀåÀ» ¸Ã¾Æ 1Çü ´ç´¢ ȯÀÚµéÀ» À§ÇØ Àû±ØÀûÀ¸·Î ¸ñ¼Ò¸®¸¦ ³»¿Ô´Ù. ¶ÇÇÑ, ¿¬¼ÓÇ÷´çÃøÁ¤±â(CGM)¸¦ ÀÌ¿ëÇÑ È¿À²ÀûÀÎ Ç÷´ç °ü¸® ±Ù°Å¸¦ ¸¶·ÃÇÏ´Â ¿¬±¸¸¦ ¼öÇàÇÏ¿´´Ù. ÃÖ±Ù¿¡´Â 1Çü, 2ÇüÀ¸·Î ±¸ºÐµÈ ÇöÇà ´ç´¢º´ ºÐ·ùü°è¸¦ ³Ñ¾î, °úÇÐÀû ±Ù°Å¿¡ ±â¹ÝÇÑ ÃéµµºÎÀü ´Ü°èº° »õ·Î¿î ºÐ·ùü°è¸¦ Á¤¸³ÇÏ´Â µ¥ ÈûÀ» º¸ÅÂ¸ç ´ç´¢º´ Áø·áÀÇ ÆÐ·¯´ÙÀÓ º¯È­¸¦ ¼±µµÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¼­¿ï´ë ÀÇ´ë Çлç
  • ¼­¿ï´ë ÀÇ´ë ¼®»ç
  • ¼­¿ï´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѳ»ºÐºñÇÐȸ
  • ´ëÇÑ´ç´¢º´ÇÐȸ
  • ´ëÇÑ À̽ÄÇÐȸ
  • ¹Ì±¹´ç´¢º´ÇÐȸ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks
¹ßÇ¥³âµµ 2026 ¹ßÇ¥Áö Diabetologia
Á¦ ¸ñ Elevated triglyceride-glucose index is a risk factor for cardiovascular events in adults with type 1 diabetes: a cohort study
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Cardiovascular Diabetology
Á¦ ¸ñ Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö Diabetologia
Á¦ ¸ñ Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
¹ßÇ¥³âµµ 2024 ¹ßÇ¥Áö Diabetologia
Á¦ ¸ñ An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Diabetes Care
Á¦ ¸ñ DAMP-modulating nanoparticle for successful pancreatic islet and stem cell transplantation
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Biomaterials
Á¦ ¸ñ The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Cardiovascular Diabetology

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

»ï¼º¼­¿ïº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1599-3114

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

»ï¼º¼­¿ïº´¿øÀº 1994³â °³¿øÇÑ Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î º»°ü, º°°ü, ¾Ïº´µ¿À¸·Î ±¸¼ºµÅ ÀÖÀ¸¸ç ¾à 1979º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. 2014³â ¾ç¼ºÀÚ Ä¡·á¼¾ÅÍ, 2015³â ¹Ì·¡ ÀÇÇаüÀÌ ¿Ï°øµÆÀ¸¸ç, ÇöÀç 2019³â ¿Ï°øÀ» ¸ñÇ¥·Î Åë¿øÄ¡·á¼¾ÅÍ °ø»ç¸¦ ÁøÇàÇϰí ÀÖ´Ù. ȯÀÚ ÇູÀ» À§ÇÑ ÀÇ·á Çõ½Å ±¸Çö, º´¿ø-¿¬±¸¼Ò-Çб³-±â¾÷ü¸¦ ¿¬°áÇÏ´Â ¹ÙÀÌ¿À ÇコÄÉ¾î ¿¬±¸ ¹× ¿¬°è »ê¾÷ÀÇ ±Û·Î¹ú Çãºê¸¦ ¸ñÇ¥·Î ÇÑ´Ù.

»ï¼º¼­¿ïº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã °­³²±¸ ÀÏ¿ø·Î 81

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä